REBECCA AGNEW: Open Payments
NPI 1881616001 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 5 payments from 4 companies in 2025. Trend: 2023 $2,085 · 2024 $828 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 2 | $144 |
| Apellis Pharmaceuticals, Inc. | 1 | $115 |
| Travere Therapeutics, Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: Empaveli, XPHOZAH 30 MG, IBSRELA, JYNARQUE.
Industry payments across PA — which companies pay providers there.
